About This Research Study
Systemic sclerosis (scleroderma) is a rare autoimmune disease that can cause hardening and thickening of the skin and may affect internal organs, including the lungs, heart, digestive system, and kidneys. Tekton is enrolling participants for a research study evaluating an investigational medication for systemic sclerosis. Eligible participants may be compensated for study-related time and travel.
Eligible participants…
- Must be age 18+
- Must be diagnosed with Systemic Sclerosis
- May receive compensation for study-related time and travel
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Tekton enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.